Interestingly, while most cancer cell lines are sensitive to the inhibition of NF-κB pathway, the RMS cell lines can still proliferate and survive under NF-κB inhibition with the aid of MyoD transcription factor that maintains the cells in a partially differentiated state. Here, NFKB1 is linked to cancer.